Background Obesity has been proposed as a risk factor for pancreatic cancer. Methods
Pooled data were analyzed from the National Cancer Institute Pancreatic Cancer Cohort …

The broad field of gene therapy promises a number of innovative treatments that are likely to
become important in preventing deaths from cancer. In this review, we discuss the history …

Context/Objective: Approximately 15% of thyroid cancer patients develop subsequent
metastases. The clinical course of patients with metastatic thyroid carcinoma is highly …

Background Racial disparities in cancer outcomes have been observed in several
malignancies. However, it is unclear if survival differences persist after adjusting for clinical …

Racial disparities in breast cancer mortality have been widely documented for several
decades and persist despite advances in receipt of mammography across racial groups …

Objective Although pancreatic ductal adenocarcinoma is considered a rapidly progressive
disease, mathematical models estimate that it takes many years for an initiating pancreatic …

Introduction. ER, PR, and HER2 are routinely available in breast cancer specimens. The
purpose of this study is to contrast breast cancer‐specific survival for the eight ER/PR/HER2 …

Cancer is an important reason of death worldwide. Traditional cytotoxic therapies, such as
radiation and chemotherapy, are expensive and cause severe side effects. Currently, design …

Cancer pain significantly affects the diagnosis, quality of life and survival of patients with
cancer. During the past decade, preclinical and clinical data has begun to provide insight …

The histone methyltransferase EZH2 is a central epigenetic regulator of cell survival,
proliferation, and cancer stem cell (CSC) function. EZH2 expression is increased in various …